Home › Funds › EMINENCE CAPITAL, LP › MDLN
EMINENCE CAPITAL, LP position in MDLN
MEDLINE INC · Health Care
EMINENCE CAPITAL, LP reported holding 2,279,190 shares of MDLN (MEDLINE INC) in its Q1 2026 13F filing — a position valued at US$101.4M, representing 2.33% of its reported portfolio and ranking #20 among its reported holdings. EMINENCE CAPITAL, LP has disclosed MDLN holdings in 2 of the last 2 reported quarters, going back to Q4 2025.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How EMINENCE CAPITAL, LP's MDLN position evolved
EMINENCE CAPITAL, LP first disclosed a stake in MDLN in Q4 2025 at 1,505,000 shares (US$63.2M). The position peaked in Q1 2026 at 2,279,190 shares, worth US$101.4M. Across 2 filings, EMINENCE CAPITAL, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 2,279,190 shares valued at US$101.4M — an increase of 774,190 shares quarter over quarter.. Notable position changes include a 51% increase in Q1 2026 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.50M | $63.21M | New |
| Q1 2026 | 2.28M | $101.42M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDLN and 13F data
MDLN (MEDLINE INC) is a Health Care company. 116 other funds we track also report a position in MDLN — the largest reported positions include Carlyle Group Inc. (US$7.38B), Blackstone Inc. (US$4.01B), H&F Corporate Investors X, Ltd. (US$2.80B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDLN
- Carlyle Group Inc. 187.08M sh · $7.38B · Q2 2026
- Blackstone Inc. 101.79M sh · $4.01B · Q2 2026
- H&F Corporate Investors X, Ltd. 70.87M sh · $2.80B · Q2 2026
- Lone Pine Capital 20.97M sh · $826.99M · Q2 2026
- LONE PINE CAPITAL LLC 20.97M sh · $826.99M · Q2 2026
- Egerton Capital (UK) LLP 16.47M sh · $649.61M · Q2 2026
- SurgoCap Partners LP 7.49M sh · $295.31M · Q2 2026
- WCM INVESTMENT MANAGEMENT, LLC 7.40M sh · $293.02M · Q2 2026
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 7.36M sh · $290.10M · Q2 2026
- Alyeska Investment Group, L.P. 6.81M sh · $268.55M · Q2 2026
- BANQUE PICTET & CIE SA 7.46M sh · $258.69M · Q3 2026
- Unisphere Establishment 3.68M sh · $145.24M · Q2 2026
More on EMINENCE CAPITAL, LP
FAQ
How long has EMINENCE CAPITAL, LP held MDLN?
EMINENCE CAPITAL, LP has disclosed MDLN holdings in 2 of the last 2 reported quarters, going back to Q4 2025.
What is EMINENCE CAPITAL, LP's current position in MDLN?
As of Q1 2026, EMINENCE CAPITAL, LP holds 2.28M shares of MDLN (MEDLINE INC), valued at $101.42M, representing 2.33% of its reported portfolio and ranking #20.
Has EMINENCE CAPITAL, LP been buying or selling MDLN?
In the latest 13F filing (Q1 2026), EMINENCE CAPITAL, LP increased its position in MDLN. The position peaked in Q1 2026 at 2.28M shares.
Which other funds hold MDLN?
Other major institutional holders of MDLN include Carlyle Group Inc., Blackstone Inc., H&F Corporate Investors X, Ltd., among 116 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.